Search results for "Hamd"

showing 4 items of 14 documents

Comparison of Paroxetine and Maprotiline in Minor Depression

1994

Whilst the efficacy of paroxetine has been demonstrated in MDD, its clinical utility in minor depression has not been established. This study assesses the antidepressant efficacy of paroxetine in patients meeting RDC criteria for minor depression. All patients scored 13 points on the 17-item Hamilton Depression Rating Scale (HAMD) at baseline. After a 3 day washout period, patients were randomised to receive paroxetine 20–40mg/day or maprotiline 100-150mg/day, dose being titrated according to clinical response after 3 weeks treatment at the lower doses. Assessments conducted at baseline (day 0) and at weekly intervals for 6 weeks included the 17-item HAMD, the Montgomery-Asberg Depression R…

Pharmacologymedicine.medical_specialtyAntidepressant efficacyIntention-to-treat analysisbusiness.industryParoxetinePsychiatry and Mental healthRating scaleInternal medicineHamdmedicineClinical Global ImpressionPsychiatrybusinessMaprotilineDepression (differential diagnoses)medicine.drugNeuropsychopharmacology
researchProduct

EPA-0703 – Performance of the hamilton depression rating subscales to predict antidepressant treatment response in the early course of treatment

2014

Early improvement ( EI ), i.e. a symptom reduction from baseline of at least 20% after 2 weeks, has been proven to be a clinically useful predictor for later treatment outcome. In most studies EI is identified by using the sum score of the Hamilton Depression Rating Scale (HAMD). Several unidimensional subscales of the HAMD exist, which have proven to be an economic measure of treatment change. Their ability to detect onset of improvement in comparison to the full HAMD has not been researched yet. The present study investigated in patients with major depression (MD) (1) whether the HAMD subscales are a valid and economic option to predict antidepressant treatment response in the early cours…

Predictive validityPsychiatry and Mental healthReceiver operating characteristicRating scaleMirtazapineHamdmedicineAntidepressantPsychologyParoxetineDepression (differential diagnoses)medicine.drugClinical psychologyEuropean Psychiatry
researchProduct

P-491 - Sensitivity to changes during antidepressant treatment: a comparison of unidimensional depression rating scales in patients with minor depres…

2012

In the efficacy evaluation of antidepressant treatments the total score of the Hamilton Depression Rating Scale (HAMD) is still regarded as the’gold standard’. Studies suggest that unidimensional subscales of the HAMD, which capture the core depressive symptoms, outperform the full HAMD regarding the detection of antidepressant treatment effects. The present study compared several unidimensional subscales of the HAMD and the Inventory of Depressive Symptomatology (IDS) regarding their sensitivity to changes in depression symptoms in a sample of patients with minor depression (MIND). Biweekly IDS-C28 and HAMD17 data from 287 patients of a 10-week randomised, placebo-controlled trial comparin…

Sertralinemedicine.medical_specialtymedicine.medical_treatmentShort scaleGroup psychotherapyPsychiatry and Mental healthRating scaleHamdmedicineAntidepressantIn patientPsychologyPsychiatryDepression (differential diagnoses)Clinical psychologymedicine.drugEuropean Psychiatry
researchProduct

P-515 - CGI Rating to predict antidepressant treatment under naturalistic conditions

2012

Introduction Recent studies have shown that psychopathological rating by the Hamilton Depression Rating scale (HAMD) is well established and highly predictive for later response. In this study we aimed to find out if Clinical Global Impression (CGI) scale is suitable to guide antidepressive treatment under naturalistic conditions. Methods Inpatients with a major depressive disorder and treatment with citalopram were included and rated using in parallel the HAMD scale and the CGI scale weekly at baseline to day 35. According to CGI the sample has been divided in “CGI improver” (CGI = 2–4) and “CGI non-improver” (CGI = 5–6). Response was defined as HAMD sum score reduction by at least 50%. Re…

medicine.medical_specialtyCitaloprammedicine.diseasehumanitiesPsychiatry and Mental healthRating scalehealth services administrationInternal medicinemental disordersHamdClinical Global ImpressionmedicineMajor depressive disorderAntidepressantPsychiatryPsychologyPsychopathologymedicine.drugEuropean Psychiatry
researchProduct